ADVERTISEMENT
Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs
OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patent DocsBiotech Patenting Conference
By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry
ADVERTISEMENTS
C5 (UK) will be holding its 18th Forum on Biotech Patenting on March 17-18, 2010 in Munich, Germany. C5 faculty will provide information and insights into: ? Strategies for adapting your patent practice to EPO rule changes; ? The latest EPO requirements for the patentability of biotechnological inventions; ? The practical impact of major EPO and national court cases; ? Disclosure requirements for gene patents -- what is patenable? From T1329/04 to Eli Lily vs. HGS; ? Second Medical Use Claims: How to draft your claims in light of the Enlarged Board's Decision and national case law; ? The evolving...Full post as published by Patent Docs on January 23, 2010 (boomark / email).
Lawsuits and Settlements
Bayer CropScience AG
alleging farmers suffered economic losses after Bayer's biotech Liberty Link rice was released into the food supply and countries banned US rice.
Related Searches
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.

C5 "Biotech Patenting" Conference, London, September 23-24
ACI "Biotech Patents" Conference, Boston, September 15-16
Biotech Patents: How To Face New Challenges
ACI "Pharma/Biotech IP Due Diligence" Conference, New York, January 30-31
Biotech Patents: Strategies for an Evolving Legal Climate
Upcoming Patent Events: Pharma/Biotech IP Due Diligence








